Publications
320
Citations
17,332
Est. group size
~6
Recurring co-author estimate
Active years
32
Publishing since 1995
Typically publishes in teams of ~28 · 0% small-team papers (≤3 authors) · across 16 venues
- COVID-19 Vaccination and Odds of Post–COVID-19 Condition Symptoms in Children Aged 5 to 17 Years
JAMA Network Open · 2025
- Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnel
Vaccine · 2025
- Hybrid Immunity and SARS-CoV-2 Antibodies: Results of the HEROES–RECOVER Prospective Cohort Study
Clinical Infectious Diseases · 2024
- Association of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination and Reductions in Post COVID Conditions Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection in a US Prospective Cohort of Essential Workers
The Journal of Infectious Diseases · 2024
- Longitudinal parental perception of COVID-19 vaccines for children in a multi-site, cohort study
Vaccine · 2024
- Evaluating Immunologic and Illness Outcomes of SARS-CoV-2 Infection in Vaccinated and Unvaccinated Children Aged ≥ 5 Years, in a Multisite Longitudinal Cohort
Diseases · 2024
- Risk reduction in SARS-CoV-2 infection and reinfection conferred by humoral antibody levels among essential workers during Omicron predominance
PLoS ONE · 2024
- Serum per- and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodies
Environmental Research · 2023
- Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers
Emerging infectious diseases · 2023
- 1935. COVID-19 mRNA Vaccination Reduces the Occurrence of Post-COVID Conditions in U.S. Children Aged 5-17 Years Following Omicron SARS-CoV-2 Infection, July 2021-September 2022
Open Forum Infectious Diseases · 2023
- Humoral Immune Response to Messenger RNA Coronavirus Disease 2019 Vaccination Among Children Aged 5–11 Years in a Multisite Prospective Cohort Study, September 2021–September 2022
Open Forum Infectious Diseases · 2023
- Determinants of <i>de novo</i> B cell responses to drifted epitopes in post-vaccination SARS-CoV-2 infections
medRxiv · 2023
- Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022
MMWR Morbidity and Mortality Weekly Report · 2022
- Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers
New England Journal of Medicine · 2022
- Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers
JAMA · 2022
- Clinical Infectious Diseases×43
- MMWR Morbidity and Mortality Weekly Report×35
- Open Forum Infectious Diseases×31
- medRxiv×28
- The Journal of Infectious Diseases×23
- Arnold S. Monto
Medicine · University of Michigan
- Jessie R. Chung
Medicine · University of Michigan
- Mark A. Katz
Medicine · University of Michigan
- Aaron M. Frutos
Medicine · University of Michigan
- Brendan Flannery
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile